Cargando…
Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles
The upper and lower eyelids are traditionally contraindicated for subcutaneous botulinum toxin A (BTX) injection because of possible complications. We assessed the clinical safety and effectiveness of nonablative fractional laser (NAFL) combined with transdermal delivery of BTX in the treatment of p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010349/ https://www.ncbi.nlm.nih.gov/pubmed/27622085 http://dx.doi.org/10.1097/GOX.0000000000001004 |
_version_ | 1782451676128477184 |
---|---|
author | Fan, Xing Yin, Yue Wang, Shiping Li, Tong Xue, Ping Yang, Qing Ma, Qiaoxin |
author_facet | Fan, Xing Yin, Yue Wang, Shiping Li, Tong Xue, Ping Yang, Qing Ma, Qiaoxin |
author_sort | Fan, Xing |
collection | PubMed |
description | The upper and lower eyelids are traditionally contraindicated for subcutaneous botulinum toxin A (BTX) injection because of possible complications. We assessed the clinical safety and effectiveness of nonablative fractional laser (NAFL) combined with transdermal delivery of BTX in the treatment of periocular wrinkles. Thirty patients who had periocular wrinkles were treated with 1,565-nm NAFL in combination in the left periocular area and normal saline in the corresponding area of the right eye. VISIA skin detector was used to photograph and compare the changes induced by treatment. We also recorded the comfort level of the patients. All 28 patients could tolerate the pain caused by the laser treatment and showed no apparent discomfort during percutaneous drug delivery. No chromatosis or ptosis of upper eyelids occurred after the treatment. We used VISIA to detect changes at 1 week, 1 month, 3 months, and 6 months, respectively, after the treatment. The periocular wrinkles decreased, and the flabbiness of eyelids was significantly reduced. The upper and lower eyelids are traditionally contraindicated for subcutaneous BTX injection, as it may cause complications. The treatment combining 1,565-nm NAFL and transdermal delivery of BTX can decrease periocular wrinkles and flabbiness while avoiding complications to the greatest extent. None of the 28 patients who had completed the treatment suffered from complications or adverse effects; all were satisfied with the treatment outcome. |
format | Online Article Text |
id | pubmed-5010349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-50103492016-09-12 Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles Fan, Xing Yin, Yue Wang, Shiping Li, Tong Xue, Ping Yang, Qing Ma, Qiaoxin Plast Reconstr Surg Glob Open Ideas and Innovations The upper and lower eyelids are traditionally contraindicated for subcutaneous botulinum toxin A (BTX) injection because of possible complications. We assessed the clinical safety and effectiveness of nonablative fractional laser (NAFL) combined with transdermal delivery of BTX in the treatment of periocular wrinkles. Thirty patients who had periocular wrinkles were treated with 1,565-nm NAFL in combination in the left periocular area and normal saline in the corresponding area of the right eye. VISIA skin detector was used to photograph and compare the changes induced by treatment. We also recorded the comfort level of the patients. All 28 patients could tolerate the pain caused by the laser treatment and showed no apparent discomfort during percutaneous drug delivery. No chromatosis or ptosis of upper eyelids occurred after the treatment. We used VISIA to detect changes at 1 week, 1 month, 3 months, and 6 months, respectively, after the treatment. The periocular wrinkles decreased, and the flabbiness of eyelids was significantly reduced. The upper and lower eyelids are traditionally contraindicated for subcutaneous BTX injection, as it may cause complications. The treatment combining 1,565-nm NAFL and transdermal delivery of BTX can decrease periocular wrinkles and flabbiness while avoiding complications to the greatest extent. None of the 28 patients who had completed the treatment suffered from complications or adverse effects; all were satisfied with the treatment outcome. Wolters Kluwer Health 2016-08-30 /pmc/articles/PMC5010349/ /pubmed/27622085 http://dx.doi.org/10.1097/GOX.0000000000001004 Text en Copyright © 2016 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Ideas and Innovations Fan, Xing Yin, Yue Wang, Shiping Li, Tong Xue, Ping Yang, Qing Ma, Qiaoxin Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title | Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title_full | Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title_fullStr | Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title_full_unstemmed | Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title_short | Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with Transdermal Delivery of Botulinum Toxin A in Treating Periocular Wrinkles |
title_sort | clinical assessment of the safety and effectiveness of nonablative fractional laser combined with transdermal delivery of botulinum toxin a in treating periocular wrinkles |
topic | Ideas and Innovations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010349/ https://www.ncbi.nlm.nih.gov/pubmed/27622085 http://dx.doi.org/10.1097/GOX.0000000000001004 |
work_keys_str_mv | AT fanxing clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT yinyue clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT wangshiping clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT litong clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT xueping clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT yangqing clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles AT maqiaoxin clinicalassessmentofthesafetyandeffectivenessofnonablativefractionallasercombinedwithtransdermaldeliveryofbotulinumtoxinaintreatingperiocularwrinkles |